ReviewPharmaceuticals (Basel, Switzerland)2026

Neuroprotective Potential of SGLT2 Inhibitors in Animal Models of Alzheimer's Disease and Type 2 Diabetes Mellitus: A Systematic Review.

Azim Haikal Md Roslan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.